Company / Interest Expense per Share
RIGEL PHARMACEUTICALS INC Interest Expense per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.45
FY2024
5-year range
$0.02 / $0.45
FY2020-FY2024
Trend
+1042.8%
vs FY2023
Sector context
#12 of 43
Health Care
What the data says
Interest Expense per Share changed +1043% YoY in FY2024, a notable deviation from the 5-year average annual change of +332%.
Based on SEC 10-K filings.
0.45 in FY2024 with a 5-year CAGR of +195.7%.
Increased from $0.02 to $0.45 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +150.8%
- 5-Year CAGR
- +195.7%
- 10-Year CAGR
- -
Sector benchmark
#32 of 43 in Health CareTop 72% of 43This company $0.45 Sector average $9.80
▼
-95.4% below sector average
Key checks
Key Insights
- In FY2024, interest expense per share increased 1042.8% year-over-year.
- Ranks #12 out of 43 companies in the Health Care sector.
- Lowest interest expense per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0.45 | +1042.8% |
| FY2023 | $0.04 | +83.5% |
| FY2022 | $0.02 | -24.7% |
| FY2021 | $0.03 | +256.4% |
| FY2020 | $0.01 | +301.9% |
| FY2019 | $0.00 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026